279. Astleford K, Campbell E, Norton A, Mansky KC. Epigenetic Regulators Involved in Osteoclast Differentiation. *Int J Mol Sci* (2020) 21:1–15. doi: 10.3390/ijms21197080

280. Martinez-Moreno JM, Fontecha-Barriuso M, Martin-Sanchez D, Guerrero-Mauvecin J, Goma-Garces E, Fernandez-Fernandez B, et al. Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease. *Int J Mol Sci* (2020) 21:1–26. doi: 10.3390/ijms21114113

281. Kwon DH, Ryu J, Kim YK, Kook H. Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification. *Int J Mol Sci* (2020) 21(9):3246. doi: 10.3390/ijms21093246

282. Lin W, Li Y, Chen F, Yin S, Liu Z, Cao W. Klotho Preservation via Histone Deacetylase Inhibition Attenuates Chronic Kidney Disease-Associated Bone Injury in Mice. *Sci Rep* (2017) 7(1):46195. doi: 10.1038/srep46195

283. Silva AM, Moura SR, Teixeira JH, Barbosa MA, Santos SG, Almeida MI. Long Noncoding RNAs: A Missing Link in Osteoporosis. *Bone Res* (2019) 7:10. doi: 10.1038/s41413-019-0048-9

284. Srinivasan S, Duval MX, Kaimal V, Cuff C, Clarke SH. Assessment of Methods for Serum Extracellular Vesicle Small RNA Sequencing to Support Biomarker Development. *J Extracell Vesicles* (2019) 8(1):1684425. doi: 10.1080/20013078.2019.1684425

285. Ge XQ, Lin H. Noncoding RNAs in the Regulation of DNA Replication. *Trends Biochem Sci* (2014) 39:341–3. doi: 10.1016/j.tibs.2014.06.003

286. Beroual W, Brilli M, Biondi EG. Non-Coding RNAs Potentially Controlling Cell Cycle in the Model Caulobacter Crescentus: A Bioinformatic Approach. *Front Genet* (2018) 9:164. doi: 10.3389/fgene.2018.00164

287. Pircher A, Gebetsberger J, Polacek N. Ribosome-Associated ncRNAs: An Emerging Class of Translation Regulators. *RNA Biol* (2014) 11(11):1335–9. doi: 10.1080/15476286.2014.996459

288. Will CL, Lührmann R. Spliceosome Structure and Function. *Cold Spring Harb Perspect Biol* (2011) 3(7):1–2. doi: 10.1101/cshperspect.a003707

289. Dykes IM, Emanueli C. Transcriptional and Post-Transcriptional Gene Regulation by Long Non-Coding RNA. *Genomics Proteomics Bioinf* (2017) 15:177–86. doi: 10.1016/j.gpb.2016.12.005

290. Foessl I, Kotzbeck P, Obermayer-Pietsch B. miRNAs as Novel Biomarkers for Bone Related Diseases. *J Lab Precis Med* (2019) 4:2–2. doi: 10.21037/jlpm.2018.12.06

291. Yavropoulou M, Anastasilakis A, Makras P, Grammatiki M, Kotsa K, Yovos J. Circulating microRNAs in Postmenopausal Women With Osteoporosis and Vertebral Fractures. *Bone Abstr* (2016) 5:245. doi: 10.1530/boneabs.5.P245

292. Hassan MQ, Tye CE, Stein GS, Lian JB. Non-Coding RNAs: Epigenetic Regulators of Bone Development and Homeostasis. *Bone* (2015) 81:746–56. doi: 10.1016/j.bone.2015.05.026

293. Hacld M, Heilmeier U, Weilner S, Grillari J. Circulating microRNAs as Novel Biomarkers for Bone Diseases – Complex Signatures for Multifactorial Diseases? *Mol Cell Endocrinol* (2016) 432:83–95. doi: 10.1016/j.mce.2015.10.015

294. Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, et al. Circulating Exosomal Noncoding RNAs as Prognostic Biomarkers in Human Hepatocellular Carcinoma. *Int J Cancer* (2019) 144(6):1444–52. doi: 10.1002/ijc.31931

295. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, et al. MicroRNA Control of Bone Formation and Homeostasis. *Nat Rev Endocrinol* (2012) 8(4):212–27. doi: 10.1038/nrendo.2011.234

296. Masuda T, Mori A, Ito S, Ohtsuki S. Quantitative and Targeted Proteomics-Based Identification and Validation of Drug Efficacy Biomarkers. *Drug Metab* (2021) 36:100361. doi: 10.1016/j.dmpk.2020.09.006

297. Lee JH, Cho JY. Proteomics Approaches for the Studies of Bone Metabolism. *BMB Rep* (2014) 47(3):141–8. doi: 10.5483/BMBRep.2014.47.3.270

298. Nielson CM, Jacobs JM, Orwoll ES. Proteomic Studies of Bone and Skeletal Health Outcomes. *Bone* (2019) 126:18–26. doi: 10.1016/j.bone.2019.03.032

299. Calciolari E, Donos N. Proteomic and Transcriptomic Approaches for Studying Bone Regeneration in Health and Systemically Compromised Conditions. *Proteomics – Clin Appl* (2020) 14(3):1900084. doi: 10.1002/prca.201900084

300. Yang TL, Shen H, Liu A, Dong SS, Zhang L, Deng FY, et al. A Road Map for Understanding Molecular and Genetic Determinants of Osteoporosis. *Nat Rev Endocrinol* (2020) 16:91–103. doi: 10.1038/s41574-019-0282-7

301. Ohlsson C, Sjögren K. Effects of the Gut Microbiota on Bone Mass. *Trends Endocrinol Metab* (2015) 26:69–74. doi: 10.1016/j.tem.2014.11.004

302. Medina-Gomez C. Bone and the Gut Microbiome: A New Dimension. *J Lab Precis Med* (2018) 3:96–6. doi: 10.21037/jlpm.2018.11.03

303. Ohlsson C, Sjögren K. Osteomicrobiology: A New Cross-Disciplinary Research Field. *Calcified Tissue Int* (2018) 102:426–32. doi: 10.1007/s00223-017-0336-6

304. Guss JD, Horsfield MW, Fontenele FF, Sandoval TN, Luna M, Apoorva F, et al. Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material Properties. *J Bone Miner Res* (2017) 32(6):1343–53. doi: 10.1002/jbmr.3114

305. Jansson PA, Curiac D, Lazou Ahrén I, Hansson F, Martinsson Niskanen T, Sjögren K, et al. Probiotic Treatment Using a Mix of Three Lactobacillus Strains for Lumbar Spine Bone Loss in Postmenopausal Women: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial. *Lancet Rheumatol* (2019) 1(3):e154–62. doi: 10.1016/S2665-9913(19)30068-2

306. Nilsson AG, Sundh D, Bäckhed F, Lorentzon M. *Lactobacillus Reuteri* Reduces Bone Loss in Older Women With Low Bone Mineral Density: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial. *J Intern Med* (2018) 284(3):307–17. doi: 10.1111/joim.12805

307. Heale R, Forbes D. Understanding Triangulation in Research. *Evidence-Based Nursing* (2013) 16:98. doi: 10.1136/eb-2013-101494

**Conflict of Interest:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Publisher's Note:** All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Copyright © 2021 Foessl, Bassett, Bjornerem, Busse, Calado, Chavassieux, Christou, Douni, Fiedler, Fonseca, Hassler, Högler, Kague, Karasik, Khashayar, Langdahl, Leitch, Lopes, Markozannes, McGuigan, Medina-Gomez, Ntzani, Oei, Ohlsson, Szulc, Tobias, Trajanoska, Tuzun, Valjevac, van Rietbergen, Williams, Zekic, Rivadeneira and Obermayer-Pietsch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.